Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan
Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan ( Dr Kei Muro - Aichi Cancer Center Hospital, Nagoya, Japan )
7 Oct 2013
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for...
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Centre, Los Angeles, USA )
7 Oct 2013
Development of bio-similar drugs
Dr Javier Cortés - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Development of bio-similar drugs ( Dr Javier Cortés - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
4 Oct 2013
Molecular biology guiding treatment of gastrointestinal stromal tumours (GISTs)
Dr Javier Martin-Broto - Son Espases Hospital, Palme de Mallorca, Spain
Molecular biology guiding treatment of gastrointestinal stromal tumours (GISTs) ( Dr Javier Martin-Broto - Son Espases Hospital, Palme de Mallorca, Spain )
4 Oct 2013
Analysis of progression free survival versus overall survival in melanoma
Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA
Analysis of progression free survival versus overall survival in melanoma ( Dr Keith Flaherty - Dana-Farber Cancer Institute, Boston, USA )
3 Oct 2013
New antibody drug, MPDL3280A, in non-small cell lung cancer
Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France
New antibody drug, MPDL3280A, in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France )
3 Oct 2013
Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable...
Prof Dirk Schadendorf - Universitätsklinikum Essen, Essen, Germany
Meta-analysis of ipilimumab in metastatic or locally advanced, unresectable melanoma ( Prof Dirk Schadendorf - Universitätsklinikum Essen, Essen, Germany )
3 Oct 2013
Biomarkers in the BOLERO3 trial
Prof Guy Jerusalem - Centre Hospitalier Universitaire du Sart-Tilman, Liège...
Biomarkers in the BOLERO3 trial ( Prof Guy Jerusalem - Centre Hospitalier Universitaire du Sart-Tilman, Liège, Belgium )
3 Oct 2013
Aspirin may act on blood platelets to improve survival in colon cancer patients
Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013
Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian...
Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK
Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer ( Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK )
30 Sep 2013
Research shows how aspirin may act on blood platelets to improve survival in...
Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair
Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
29 Sep 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation